Companies › FLGT

FULGENT GENETICS INC (FLGT)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001674930 · EDGAR filings · Updated 2026-07-28

FULGENT GENETICS INC (FLGT) has reported institutional ownership of 61.4%, with 157 institutional managers holding positions valued at $277.5M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01).

Filings this week (3)

• 2026-07-28 — Insider transaction reported (Form 4)
• 2026-07-28 — Insider transaction reported (Form 4)
• 2026-07-28 — Insider transaction reported (Form 4)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-06-03 — Insider transaction reported (Form 4)
• 2026-06-03 — Insider transaction reported (Form 4)
• 2026-06-03 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, FULGENT GENETICS INC has 157 institutional holders and institutional ownership of 61.4%.

Insider activity

Insiders reported 96 transactions (0 buys, 19 sells) across 7 reporting insiders, with a net reported value of −$673.3K.

Data flags from SEC filings

Related companies

KYVERNA THERAPEUTICS INC (KYTX) · AQUESTIVE THERAPEUTICS INC (AQST) · INVIVYD INC (IVVD) · CERUS CORP (CERS) · CORMEDIX INC (CRMD) · STANDARD BIOTOOLS INC (LAB)